The use of dermal fibroblasts as a predictive tool of the toll-like receptor 4 response pathway and its development in Holstein heifers.
The innate immune system comprises the host's first line of defense against invading pathogens, and variation in the magnitude of this response between animals has been shown to affect susceptibility to mastitis. The toll-like receptor (TLR) family of proteins initiates the response to invading bacteria, specifically with TLR4 recognizing lipopolysaccharide (LPS) of gram-negative microbes. The underlying genetic variation in the TLR4 pathway leading to differential response is not well understood; therefore, the objective of this work was to determine the efficacy in which the response to LPS by dermal fibroblasts could be used to predict the actual systemic response of that animal to an intravenous endotoxin challenge. To accomplish this, dermal fibroblasts were isolated from 15 Holstein heifers at 5, 11, and 16 mo of age and exposed to either LPS or IL-1β; then, the production of IL-8 in medium was quantified by ELISA. Animals were ranked based upon the magnitude of the fibroblast IL-8 response, and 8 heifers were selected [4 low responders (LR) and 4 high responders (HR)] for challenge with an intravenous bolus dose (0.5 μg/kg of body weight) of LPS. Overall, between-animal variation in fibroblast IL-8 production following LPS or IL-1β was high, indicating appreciable differences in the TLR4 pathway of the animals. Ranking of the fibroblast responses was consistent across the 3 sampling times for each animal; however, the absolute response increased, and the age at which the fibroblasts were obtained was consistent with the potential for age-related changes in cell function to affect immune function processes. Following systemic LPS challenge, HR heifers had higher plasma concentrations of tumor necrosis factor-α and IL-8 than LR heifers. However, LR heifers had a stronger febrile response than HR heifers. The use of dermal fibroblasts under laboratory conditions appears to represent a practical model for predicting the innate immune response in vivo and could act as an important tool in mapping genetic differences of the TLR4 pathway.
Department of Animal Science, College of Agriculture and Life Science, University of Vermont, Burlington, Vermont 05405, USA.
B B
BB
Green
S
S
Kandasamy
T H
TH
Elsasser
D E
DE
Kerr
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D003612:Dairying / Q000379:methods*; D005260:Female; D005347:Fibroblasts / Q000187:drug effects* / Q000276:immunology; D007113:Immunity, Innate / Q000276:immunology*; D053583:Interleukin-1beta / Q000494:pharmacology; D016209:Interleukin-8 / Q000276:immunology; D008070:Lipopolysaccharides / Q000494:pharmacology*; D011237:Predictive Value of Tests; D012867:Skin / Q000166:cytology; D051197:Toll-Like Receptor 4 / Q000276:immunology*
D000276:Adjuvants, Immunologic; D053583:Interleukin-1beta; D016209:Interleukin-8; D008070:Lipopolysaccharides; D051197:Toll-Like Receptor 4